Dr. Ramesh Babu Avula, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1515 Lake Lansing Rd, G-1, Lansing, MI 48912 Phone: 517-484-3966 Fax: 517-484-9279 |
Dr. Satish K Gupta, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4265 Five Oaks Dr, Lansing, MI 48911 Phone: 517-484-2261 Fax: 517-484-6666 |
Dr. Ridhu Chopra Burton, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 4169 Legacy Pkwy, Lansing, MI 48911 Phone: 517-394-6500 Fax: 517-393-4202 |
Dr. James H. Saker, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Not Enrolled in Medicare Practice Location: 4169 Legacy Pkwy, Lansing, MI 48911 Phone: 517-394-6500 Fax: 517-393-4202 |
Dr. Clyde R. Flory Jr., M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Medicare Enrolled Practice Location: 4169 Legacy Pkwy, Lansing, MI 48911 Phone: 517-394-6500 Fax: 517-393-4202 |
News Archive
A new study by the University of Toronto, released today, found that those with schizophrenia who'd been physically abused during childhood were five times more likely to have attempted suicide.
Sanofi-aventis and its subsidiary, BiPar Sciences, today announced that a randomized Phase III trial evaluating iniparib (BSI-201) in patients with metastatic triple-negative breast cancer (mTNBC) did not meet the pre-specified criteria for significance for co-primary endpoints of overall survival and progression-free survival
IBM today announced the expansion of its Health Analytics Solution Center. Located in Dallas, the center is adding new technology and has doubled the number of healthcare solution architects and technology specialists working at the center.
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot Line session today at ESC Congress 2020.
The U.S. Food and Drug Administration today allowed marketing of the first hand-held device intended to aid in the detection of life-threatening bleeding in the skull called intracranial hematomas, using near-infrared spectroscopy.
› Verified 2 days ago